Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Total Non-Current Liabilities (2016 - 2026)

Neuroone Medical Technologies filings provide 7 years of Total Non-Current Liabilities readings, the most recent being $1.8 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 9.57% to $1.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.8 million, a 9.57% decrease, with the full-year FY2025 number at $2.4 million, up 1.6% from a year prior.
  • Total Non-Current Liabilities hit $1.8 million in Q1 2026 for Neuroone Medical Technologies, up from $1.4 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $2.4 million in Q3 2025 to a low of $1.4 million in Q4 2025.
  • Median Total Non-Current Liabilities over the past 3 years was $1.8 million (2024), compared with a mean of $1.9 million.
  • The widest YoY moves for Total Non-Current Liabilities: up 1.6% in 2025, down 24.3% in 2025.
  • Neuroone Medical Technologies' Total Non-Current Liabilities stood at $1.8 million in 2024, then fell by 24.3% to $1.4 million in 2025, then soared by 30.17% to $1.8 million in 2026.
  • The last three reported values for Total Non-Current Liabilities were $1.8 million (Q1 2026), $1.4 million (Q4 2025), and $2.4 million (Q3 2025) per Business Quant data.